Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, will announce its unaudited interim results for the six months ended 30 June 2023 on Thursday 28 September 2023.
Alistair Smith, CEO and Tony Gardiner, CFO will provide a live presentation via Investor Meet Company on Thursday 28 September 2023 at 11:00 am BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00 am BST the day before the meeting.
Investors can sign up to Investor Meet Company for free and add to meet AVACTA GROUP PLC via:
https://www.investormeetcompany.com/avacta-group-plc/register-investor.
Investors who already follow Avacta on the Investor Meet Company platform will automatically be invited.
The Company will also post its results presentation on its website at the following page: https://avacta.com/investors/documents-presentations.
-Ends-
For further information from Avacta Group plc, please contact:
|
Avacta Group plc Alastair Smith, Chief Executive Officer Tony Gardiner, Chief Financial Officer Michael Vinegrad, Group Communications Director
|
Tel: +44 (0) 1904 21 7070 |
